Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
Clinical trial NCT06253234 · RECRUITING
Trial details
- NCT number
- NCT06253234
- Sponsor
- Beijing Tiantan Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-02
- Primary completion
- 2025-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.